Impact of the COVID-19 Pandemic on Vaccination

NCT04657263 | Completed

• 1 other identifier: RECHMPL20_0655
• Study Type: observational
• Target: 500
• Locations: 1 country
• Sites: 1

Brief Summary

The vaccination policy is drawn up in France by the French Minister of Health, who makes public the vaccination schedule after the opinion of the High Authority of Health. Currently according to the 2019 immunization schedule, the dTP vaccine is the only mandatory in the general population with recalls in adults aged 25, 45, 65 and every 10 years. In 2011, the Ministry of Health estimated that only 50.5% of the general population was up to date against dTP. Two vaccines are recommended for person at risk of infection according to the current vaccine schedule: the flu vaccine and the pneumococcal vaccine. In fact, influenza and pneumococcal disease are more frequent and more serious in patients with chronic diseases (diabetes, cardiac insufficiency..) compared to the general population. The vaccination coverage rate of at-risk populations is dramatically below the vaccination coverage targets set by the Ministry of Health. Indeed, there are many barriers to vaccination, medical and para-medical barriers, but also individual barriers. The current COVID-19 pandemic has identified people at risk of severe infection and death risk, particularly those with co-morbidities (diabetes, cardiovascular disease, etc.). Thus, this pandemic may have contributed to change in patients' perceptions regarding both the risk of infection and the potential interest and benefit of vaccination.

Conditions

Covid19

Keywords

People over 18 years old; vaccines; immunization schedule; Infection

Outcome Measures

Primary Outcomes (1)

• number of persons at risk of infection up to date with their mandatory and recommended vaccinations during COVID19 pandemic

  number of persons at risk of infection up to date with their mandatory and recommended vaccinations during COVID19 pandemic

  1 day

Secondary Outcomes (1)

• Number of persons at risk of infection accepting COVID19 vaccination

  1 day

Study Arms (1)

Person at risk of infection according to French 2019 immunization

Person at risk of infection according to French 2019 immunization

Other: Vaccine coverage assessment

Interventions

Vaccine coverage assessment OTHER

Vaccine coverage assessment

Person at risk of infection according to French 2019 immunization

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Study population was composed of person at risk of infection cared for in participating centers

You may qualify if:

• Person at risk of infection according to french 2019 immunization schedule
• Patients aged above 18 years old

You may not qualify if:

• \- Patient \< 18 years

Sponsors & Collaborators

• University Hospital, Montpellier: lead

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

MeSH Terms

Conditions

COVID-19; Infections

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Cyril BREUKER

  University Hospital, Montpellier

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 7, 2020
• First Posted: December 8, 2020
• Study Start: November 1, 2020
• Primary Completion: May 1, 2021
• Study Completion: May 30, 2021
• Last Updated: October 25, 2021

Record last verified: 2021-10

Locations

FR (1)